SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Isotechnika
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
285 8 0 ISA
Emcee:  schzammm Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
210<i>On another matter, he said that Isotechnika is no longer working with Fteevee-6/23/2005
209Hi teevee, What do you think about this beast ISA? Message 21441961 CCondor-6/22/2005
208Isotechnika to raise $15,750,000 million through bought deal financing to furtheteevee-6/20/2005
207Isotechnika granted permission from FDA for Phase IIb kidney transplant trial Eteevee-5/12/2005
206Isotechnika Inc. announced that the Canadian Phase III psoriasis trial for its lteevee-4/25/2005
205Isotechnika to present at the International Congress of Therapeutic Drug Monitorteevee-4/22/2005
204new corporate presentation dated March 01-interesting comparision to biologics..teevee-3/3/2005
203-Genentech psoriasis drug effective long term-study yahoo.reuters.comschzammm-2/19/2005
202Isotechnika achieves target enrolment for Phase III psoriasis trial Thursday Febnigel bates-2/10/2005
201EDMONTON, Dec 8, 2004 /PRNewswire-FirstCall via COMTEX/ -- Isotechnika Inc. annteevee-12/8/2004
200Although Neoral sales world wide for 2004 will exceed $900M.schzammm-12/6/2004
199The assumption is that if you could produce a "safe" cyclosporine you Biomaven-12/6/2004
198I have done some "googling" on market size of Neoral for psoriasis. Thteevee-12/5/2004
197if you're asking if trans-ISA247, under that rosy hypothesis, would capture software salesperson-12/5/2004
196Thanks for the correction, sales. I was looking at a specific label I found on tBiomaven-12/5/2004
195Does anyone have any idea of the size current market for Neoral for severe psoriteevee-12/5/2004
194Peter, <I> Cyclosporine I believe doesn't have approval for psoriasissoftware salesperson-12/4/2004
193<i>It is certain the incidence of cancers will increase with transISAtx247Biomaven-12/4/2004
192Biomaven, A two year rat carcinogenicity trial will start in 2005. It is certainteevee-12/4/2004
191Isotechnika seem confident about a "therapeutic window" with respect tteevee-12/3/2004
190Yes - the key with this drug is going to be the safety profile, not the efficacyBiomaven-12/3/2004
189According to the conference call, once the trial is over, patients can opt to stteevee-12/2/2004
188Most psoriasis trials don't go as long as 24 weeks - e.g, Amevive was a 12 wBiomaven-12/2/2004
187Jason, I do not remember ever seeing a trial design with the placebo arm for halschzammm-12/2/2004
186<i>The trial design seems strange. They only have a placebo arm for half tnsaf-12/1/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News